Company Financials

Sansure Biotech, Inc. Financials

Renminbi

business Sansure Biotech, Inc. Company Profile

Main Stock Listing

SSE: 688289

Market Capitalization CN¥11.21 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 46.12
Forward PE 23.94
Price to Sales TTM CN¥6.56
Price to Book MRQ CN¥1.52
Enterprise to Revenue 4.82
Enterprise to EBITDA 28.13

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-06-30
Profit Margin 16.26%
Operating Margin 4.44%
Return on Assets TTM 0.80%
Return on Equity TTM 3.09%

Income Statement

Revenue TTM CN¥1,669,619,968
Revenue per Share TTM CN¥2.83
Quarterly Revenue Growth 19.00%
Gross Profit TTM CN¥1,286,011,008
EBITDA CN¥226,843,165
Net Income to Common TTM CN¥271,490,496
Diluted EPS TTM CN¥0.41
Quarterly Earnings Growth YoY -26.10%

Balance Sheet

Total Cash MRQ CN¥4,005,110,016
Total Cash per Share MRQ CN¥6.98
Total Debt MRQ CN¥
Total Debt to Equity MRQ 15.27
Current Ratio MRQ 4.88
Book Value per Share MRQ CN¥12.42

Cash Flow

Operating Cash Flow TTM CN¥199,946,656
Levered Free Cash Flow TTM CN¥31,569,846

688289 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 579,388,006
Float Shares 280,595,342
Avg 10 Volume 3,135,141
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 50.13%
% Held by Institutions 6.93%

Stock Price Summary

Beta 0.82
Fifty Two Week Low CN¥17.73
Fifty Two Week High CN¥26.36
Fifty Two Week Change -15.71%
Day 50 MA CN¥20.38
Day 200 MA CN¥20.62

Dividends and Splits

Forward Annual Dividend Rate CN¥0.52
Forward Annual Dividend Yield 2.77%
Trailing Annual Dividend Rate CN¥0.54
Trailing Annual Dividend Yield 2.84%
Payout Ratio 130.98%
Dividend Date
Ex Dividend Date 2025-09-23
Last Split Factor
Last Split Date 2022-06-01